Perivascular Adipose Tissue – Orchestrator of Cardiovascular Disturbances Sequel.

Perivascular adipose tissue is a biologically active morphofunctional unit that is an active regulator of endovascular homeostasis, endothelial functioning, and the phenotypic state of smooth muscle. Under physiological conditions, perivascular adipose tissue maintains normal vascular function by releasing anti-atherogenic, anti-inflammatory, and vasodilating biologically active substances. Until recently, adipose tissue was considered a morphological unit with only a thermoregulatory and shock-absorbing function; however, with the development and improvement of modern medical science, we can confidently assert that adipose tissue is a factory for the production of biologically active substances with a broad spectrum of action. The released biologically active substances have both autocrine and paracrine effects, thus playing a pivotal role in maintaining the morphophysiological balance of the whole organism. Various theories are put forward about the possible key role of perivascular adipose tissue in the pathogenesis of various diseases. It has been shown that perivascular tissue is an independent cardiovascular risk factor, even without visceral obesity. When exposed to specific pathogens, the regulation of adipocytes is disrupted, and a subsequent rearrangement of the adipocyte production profile occurs. The secretion of damaged adipocytes exhibits the following properties: anti-atherogenic, anti-inflammatory, and vasodilating, with subsequent initiation or progression of cardiovascular disease. Within the framework of this review article, the following are raised and comprehensively discussed: the function of perivascular adipose tissue in health and disease and its contribution to the pathogenesis of cardiovascular disease. This review aims to analyze the data of modern literature, reflecting the photomorphogenesis of changes in the secretory activity of perivascular adipose tissue, along with the molecular mechanisms of cardiovascular system alteration.

[1]  S. Nomura,et al.  Beiging of perivascular adipose tissue regulates its inflammation and vascular remodeling , 2022, Nature Communications.

[2]  A. Gotlieb,et al.  The pathobiology of perivascular adipose tissue (PVAT), the fourth layer of the blood vessel wall. , 2022, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[3]  N. Xia,et al.  Endothelial Nitric Oxide Synthase in the Perivascular Adipose Tissue , 2022, Biomedicines.

[4]  N. Pogosova,et al.  Sequelae of COVID-19 at long-term follow-up after hospitalization , 2022, Rational Pharmacotherapy in Cardiology.

[5]  P. Hovmand,et al.  Using Systems Science for Strategic Planning of Obesity Prevention and Treatment: The Roundtable on Obesity Solutions Experience. , 2022, Current problems in cardiology.

[6]  A. Avagimyan THE PATHOPHYSIOLOGICAL BASIS OF DIABETIC CARDIOMYOPATHY DEVELOPMENT. , 2022, Current problems in cardiology.

[7]  W. Myśliński,et al.  The Role of Obesity-Induced Perivascular Adipose Tissue (PVAT) Dysfunction in Vascular Homeostasis , 2021, Nutrients.

[8]  G. Jagadeesh,et al.  The physiologic and physiopathologic roles of perivascular adipose tissue and its interactions with blood vessels and the renin-angiotensin system. , 2021, Pharmacological research.

[9]  Yunxia Liu,et al.  Role of Inflammation in Vascular Disease-Related Perivascular Adipose Tissue Dysfunction , 2021, Frontiers in Endocrinology.

[10]  A. Pini,et al.  Perivascular Adipose Tissue Attenuation on Computed Tomography beyond the Coronary Arteries. A Systematic Review , 2021, Diagnostics.

[11]  Fang Han,et al.  Relationships Between Perivascular Adipose Tissue and Abdominal Aortic Aneurysms , 2021, Frontiers in Endocrinology.

[12]  P. Dobrzyn,et al.  Role of Perivascular Adipose Tissue-Derived Adiponectin in Vascular Homeostasis , 2021, Cells.

[13]  N. Sarrafzadegan,et al.  Anthracycline Associated Disturbances of Cardiovascular Homeostasis. , 2021, Current problems in cardiology.

[14]  D. Mikhailidis,et al.  Perivascular Adipose Tissue: Pathophysiological Links With Inflammation, Atherosclerosis, and Thrombosis , 2021, Angiology.

[15]  Randall W. Bryner,et al.  Chronic stress induced perivascular adipose tissue impairment of aortic function and the therapeutic effect of exercise , 2021, Experimental physiology.

[16]  Q. Tang,et al.  BMP4-mediated browning of perivascular adipose tissue governs an anti-inflammatory program and prevents atherosclerosis , 2021, Redox biology.

[17]  Marenao Tanaka,et al.  Antiatherosclerotic Phenotype of Perivascular Adipose Tissue Surrounding the Saphenous Vein in Coronary Artery Bypass Grafting , 2021, Journal of the American Heart Association.

[18]  N. Weintraub,et al.  Macrophage immunometabolism in perivascular adipose tissue. , 2021, Arteriosclerosis, thrombosis, and vascular biology.

[19]  A. Eid,et al.  Adipose Tissue Immunomodulation: A Novel Therapeutic Approach in Cardiovascular and Metabolic Diseases , 2020, Frontiers in Cardiovascular Medicine.

[20]  A. Heagerty,et al.  Interleukin-33 rescues perivascular adipose tissue anti-contractile function in obesity. , 2020, American journal of physiology. Heart and circulatory physiology.

[21]  V. Malladi,et al.  Perivascular Mesenchymal Cells Control Adipose Tissue Macrophage Accrual in Obesity , 2020, Nature Metabolism.

[22]  Ha Won Kim,et al.  ATVB IN FOCUS: Adipose Tissue and Vascular and Immune Cell Cross Talk: Implications for Obesity and Vascular Disease , 2020 .

[23]  S. Withers,et al.  Perivascular adipose tissue: An immune cell metropolis , 2020, Experimental physiology.

[24]  N. Xia,et al.  Perivascular Adipose Tissue as a Target for Antioxidant Therapy for Cardiovascular Complications , 2020, Antioxidants.

[25]  R. Tostes,et al.  Modulation of vascular function by perivascular adipose tissue: sex differences. , 2020, Current pharmaceutical design.

[26]  J. Assreuy,et al.  Perivascular adipose tissue phenotype and sepsis vascular dysfunction: Differential contribution of NO, ROS and beta 3-adrenergic receptor. , 2020, Life sciences.

[27]  K. Zorena,et al.  Adipokines and Obesity. Potential Link to Metabolic Disorders and Chronic Complications , 2020, International journal of molecular sciences.

[28]  A. Viveiros,et al.  Targeting perivascular and epicardial adipose tissue inflammation: therapeutic opportunities for cardiovascular disease. , 2020, Clinical science.

[29]  Y. E. Chen,et al.  Perivascular Adipose Tissue Regulates Vascular Function by Targeting Vascular Smooth Muscle Cells. , 2020, Arteriosclerosis, thrombosis, and vascular biology.

[30]  C. Zheng,et al.  Sirtuin-1 and Its Relevance in Vascular Calcification , 2020, International journal of molecular sciences.

[31]  C. Sena,et al.  Perivascular adipose tissue in age-related vascular disease , 2020, Ageing Research Reviews.

[32]  M. Siedlinski,et al.  T-Cell–Derived miRNA-214 Mediates Perivascular Fibrosis in Hypertension , 2020, Circulation research.

[33]  Hai-Feng Zhang,et al.  C-reactive protein derived from perivascular adipose tissue accelerates injury-induced neointimal hyperplasia , 2020, Journal of Translational Medicine.

[34]  M. Goumans,et al.  Perivascular Adipose Tissue Controls Insulin-Stimulated Perfusion, Mitochondrial Protein Expression, and Glucose Uptake in Muscle Through Adipomuscular Arterioles , 2020, Diabetes.

[35]  Ha Won Kim,et al.  Potential role of perivascular adipose tissue in modulating atherosclerosis , 2020, Clinical science.

[36]  Жанна Давидовна Кобалава,et al.  СОВРЕМЕННАЯ ПАРАДИГМА ПАТОФИЗИОЛОГИИ, ПРОФИЛАКТИКИ И ЛЕЧЕНИЯ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТИ ПРИ САХАРНОМ ДИАБЕТЕ 2 ТИПА , 2019 .

[37]  A. Davel,et al.  Perivascular Adipose Tissue Oxidative Stress On The Pathophysiology Of Cardiometabolic Diseases. , 2019, Current hypertension reviews.

[38]  V. Pulgar Neurovascular effects of perivascular adipose tissue Regulation of sympathetic-sensory communication. , 2019, Journal of cardiovascular pharmacology.

[39]  N. Pogosova,et al.  [A Single Preventive Counseling in the Hospital Does Not Improve the Prognosis of Patients After Percutaneous Coronary Intervention]. , 2016, Kardiologiia.

[40]  H. McGee,et al.  Psychosocial aspects in cardiac rehabilitation: From theory to practice. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation of the European Society of Cardiology , 2015, European journal of preventive cardiology.